Skip to main content

Table 2 Prediction of mortality without RRT (Males)

From: BMI and its association with death and the initiation of renal replacement therapy (RRT) in a cohort of patients with chronic kidney disease (CKD)

Variables

HRs

95% CI

 

p

BMI categories

 Normal BMI

Reference group

   

 Overweight

0.65

0.45

0.92

0.016

 Mild obesity

0.60

0.40

0.90

0.013

 Moderate obesity+

0.77

0.50

1.19

0.239

 Age > =68 years

2.33

1.64

3.32

< 0.001

CKD stage

 Stage 1

Reference group

   

 Stage 2

2.17

0.26

17.90

0.471

 Stage 3A

3.22

0.43

24.39

0.257

 Stage 3B

3.22

0.44

23.77

0.252

 Stage 4

5.43

0.74

39.88

0.096

 Stage 5

3.96

0.53

29.63

0.181

Primary renal diagnoses

 Glomerulonephritis

Reference group

   

 Genetic renal disease

2.65

0.74

9.53

0.136

 Diabetic nephropathy

4.15

1.72

9.99

0.002

 Renovascular disease

3.90

1.67

9.10

0.002

 Cancer

1.34

1.01

1.78

0.041

 Diabetes

1.21

0.85

1.70

0.288

 PVD

1.48

1.07

2.04

0.017

 Chronic lung disease

1.14

0.86

1.52

0.374

 CAD

1.78

1.32

2.40

< 0.001

 All other CVD

1.24

0.89

1.71

0.203

IRSD quintiles

 Lowest

Reference group

   

 Low

0.93

0.63

1.37

0.718

 Middle

0.60

0.40

0.90

0.014

 High

0.60

0.40

0.91

0.015

 Highest

0.52

0.32

0.86

0.011